Classification Information
Class [10]
Medical Instrument Products
Pathology and molecular diagnostics specimen collection kits.
Class [42]
Computer & Software Services & Scientific Services
Medical research; medical and scientific research services in the fields of anatomic pathology, molecular profiling, blood-based diagnostics, oncology, genomics, and proteomics; pharmaceutical research and development; genetic and proteomic research studies of specimens; genetic and proteomic research studies of specimens, namely, cellular manipulation, light microscopic examination, immunohistochemistry flow cytometry, expression profiling, microarray analysis, genetic signatures, specific genetic targets, DNAIRNA isolation and western blot analysis, facilitating effective clinical trials, product development, and research using large amounts of biospecimens and associated research and patient data; providing temporary use of non-downloadable software for tracking laboratory information featuring customized biospecimens and coordinating and conducting follow-on studies to complement the clinical findings; medical and scientific research; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials.
Class [44]
Medical, Beauty & Agricultural Services
Medical screening services; medical diagnostic testing, monitoring and reporting services; pathology diagnostic services; prognostic analysis services; theranostic analysis services; medical services; medical testing, diagnostic, theranostic, prognostic and analysis services, including pathology diagnostics, anatomic diagnostics and molecular diagnostics services; medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; medical services, namely, providing patient history reports based on analysis of RNA, DNA and protein to aid physicians in determining diagnosis, prognosis, and predicting or monitoring therapeutic response for cancer patients; health care services, namely providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumor profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes; medical services, namely, analysis of RNA, DNA and protein to determine therapeutic options for patients.
